# Vanda Pharmaceuticals Inc.: filings

VNDA · Nasdaq · CIK 1347178 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vnda.md) · [Financials](/companies/vnda/financials.md) · [Filings](/companies/vnda/filings.md) · [Insiders](/companies/vnda/insiders.md)

## Reports and events: 361 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 373, 8-K 264, SC 13G/A 111, 10-Q 54, SC 13G 38, 3 27, DEFA14A 24, 144 19, 10-K 18, DEF 14A 18, S-8 18, 424B5 7, CT ORDER 7, CORRESP 6, UPLOAD 6, 4/A 5, 5 5, EFFECT 5, S-3 5, SCHEDULE 13G 5, SCHEDULE 13G/A 5, 8-K/A 4, ARS 4, 8-A12B/A 3, 10-K/A 2, 8-A12B 1, ARS/A 1, DFAN14A 1, PREC14A 1, S-3/A 1, S-3MEF 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 08:00 ET | [10-Q](/filings/0001347178-26-000002.md) | Quarterly report, period 2026-09-30 | 0001347178-26-000002 |
| 2026-10-28 | 16:07 ET | [8-K](/filings/0001628280-26-067886.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067886 |
| 2026-08-06 | 07:39 ET | [10-Q](/filings/0001628280-26-053855.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053855 |
| 2026-08-05 | 16:04 ET | [8-K](/filings/0001628280-26-053308.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053308 |
| 2026-06-05 | 16:38 ET | [8-K](/filings/0001628280-26-041298.md) | 5.07 Shareholder vote results | 0001628280-26-041298 |
| 2026-05-07 | 07:01 ET | [10-Q](/filings/0001628280-26-031667.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031667 |
| 2026-05-06 | 16:06 ET | [8-K](/filings/0001628280-26-031241.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031241 |
| 2026-04-23 | 16:48 ET | [DEF 14A](/filings/0001628280-26-026893.md) | Proxy statement, period 2026-06-04 | 0001628280-26-026893 |
| 2026-04-22 | 17:23 ET | [8-K](/filings/0001628280-26-026642.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-026642 |
| 2026-04-02 | 16:30 ET | [8-K](/filings/0001628280-26-023222.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-023222 |
| 2026-03-10 | 16:47 ET | [8-K](/filings/0001628280-26-016516.md) | 7.01 Regulation FD disclosure | 0001628280-26-016516 |
| 2026-02-23 | 07:00 ET | [8-K](/filings/0001628280-26-010376.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-010376 |
| 2026-02-19 | 16:31 ET | [8-K](/filings/0001628280-26-009805.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-009805 |
| 2026-02-12 | 07:04 ET | [10-K](/filings/0001628280-26-007460.md) | Annual report, period 2025-12-31 | 0001628280-26-007460 |
| 2026-02-11 | 16:05 ET | [8-K](/filings/0001628280-26-007256.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-007256 |
| 2026-01-08 | 07:09 ET | [8-K](/filings/0001628280-26-001273.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-001273 |
| 2025-12-31 | 18:45 ET | [8-K](/filings/0001628280-25-059155.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-059155 |
| 2025-12-04 | 16:39 ET | [8-K](/filings/0001628280-25-055393.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-055393 |
| 2025-11-28 | 07:06 ET | [8-K](/filings/0001628280-25-054225.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-054225 |
| 2025-10-30 | 07:23 ET | [10-Q](/filings/0001628280-25-047317.md) | Quarterly report, period 2025-09-30 | 0001628280-25-047317 |
| 2025-10-29 | 16:08 ET | [8-K](/filings/0001628280-25-047112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-047112 |
| 2025-10-01 | 17:10 ET | [8-K](/filings/0001628280-25-043489.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-043489 |
| 2025-07-31 | 08:57 ET | [10-Q](/filings/0001628280-25-036861.md) | Quarterly report, period 2025-06-30 | 0001628280-25-036861 |
| 2025-07-31 | 07:34 ET | [8-K](/filings/0001628280-25-036843.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-036843 |
| 2025-06-05 | 16:32 ET | [8-K](/filings/0001628280-25-029678.md) | 5.07 Shareholder vote results | 0001628280-25-029678 |
| 2025-05-08 | 07:06 ET | [10-Q](/filings/0001628280-25-023448.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023448 |
| 2025-05-07 | 16:07 ET | [8-K](/filings/0001628280-25-023154.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023154 |
| 2025-04-25 | 16:31 ET | [DEF 14A](/filings/0001628280-25-019987.md) | Proxy statement, period 2025-06-05 | 0001628280-25-019987 |
| 2025-03-17 | 09:15 ET | [8-K](/filings/0001193125-25-055287.md) | 7.01 Regulation FD disclosure | 0001193125-25-055287 |
| 2025-02-20 | 16:46 ET | [8-K](/filings/0001193125-25-030780.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-030780 |
| 2025-02-14 | 16:32 ET | [10-K](/filings/0001628280-25-005761.md) | Annual report, period 2024-12-31 | 0001628280-25-005761 |
| 2025-02-13 | 16:08 ET | [8-K](/filings/0001628280-25-005406.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-005406 |
| 2025-01-27 | 08:22 ET | [8-K](/filings/0001193125-25-012740.md) | 7.01 Regulation FD disclosure | 0001193125-25-012740 |
| 2024-11-07 | 07:07 ET | [10-Q](/filings/0001628280-24-045970.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045970 |
| 2024-11-06 | 16:16 ET | [8-K](/filings/0001628280-24-045724.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045724 |
| 2024-10-15 | 08:00 ET | [8-K](/filings/0001193125-24-237220.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-237220 |
| 2024-10-03 | 17:00 ET | [8-K](/filings/0001193125-24-232306.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-232306 |
| 2024-09-19 | 08:10 ET | [8-K](/filings/0001193125-24-221784.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-221784 |
| 2024-08-08 | 07:29 ET | [8-K](/filings/0001193125-24-196481.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-24-196481 |
| 2024-08-01 | 07:01 ET | [10-Q](/filings/0001628280-24-033866.md) | Quarterly report, period 2024-06-30 | 0001628280-24-033866 |
| 2024-07-31 | 16:05 ET | [8-K](/filings/0001628280-24-033743.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-033743 |
| 2024-06-20 | 16:59 ET | [8-K](/filings/0001193125-24-164545.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-164545 |
| 2024-06-13 | 16:38 ET | [8-K](/filings/0001193125-24-160755.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-160755 |
| 2024-06-06 | 16:30 ET | [8-K](/filings/0001193125-24-156117.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-156117 |
| 2024-05-24 | 16:49 ET | [8-K](/filings/0001628280-24-025254.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-025254 |
| 2024-05-24 | 16:31 ET | [8-K/A](/filings/0001628280-24-025241.md) | 5.07 Shareholder vote results | 0001628280-24-025241 |
| 2024-05-20 | 17:26 ET | [8-K](/filings/0001628280-24-024405.md) | 5.07 Shareholder vote results | 0001628280-24-024405 |
| 2024-05-09 | 07:07 ET | [10-Q](/filings/0001628280-24-021952.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021952 |
| 2024-05-08 | 16:06 ET | [8-K](/filings/0001628280-24-021658.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021658 |
| 2024-05-07 | 16:51 ET | [8-K](/filings/0001193125-24-133252.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-133252 |

Page 1 of 8. [Older](/companies/vnda/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:08 ET. No prices; not investment advice.